Arkolith/Insider Trading/ELVN/Form 4

Collins Helen Louise

CHIEF MEDICAL OFFICEREnliven Therapeutics, Inc. (ELVN) · full profile →Form 4 · filed Apr 21, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$238K
Net Open-Market Flow
-$238K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 17, 2026Option exercise(M)5K$2.48$12K30K
Apr 17, 2026Sell(S)140$45.81$6K30K
Apr 17, 2026Sell(S)2K$47.39$115K27K
Apr 17, 2026Sell(S)2K$48.06$117K25K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 17, 2026Option exercise(M)5K—$0131K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001701247-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML